## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract, without access to full methods, figures, tables, or supplementary data
- **Shared manuscript claim summary** The authors report an in silico investigation of missense single nucleotide polymorphisms (SNPs) in the human TERF1 gene, aiming to identify deleterious variants associated with male infertility. Using a stepwise computational pipeline including pathogenicity prediction, stability and conservation analysis, post-translational modification, secondary structure, functional interaction prediction, binding energy evaluation, and molecular dynamics simulation, they report that 4 of 18 SNPs (rs1486407144, rs1259659354, rs1257022048, rs1320180267) are most damaging and affect TERF1 protein function and dynamics when interacting with TERB1. They suggest these variants as potential genetic biomarkers for male infertility diagnosis.
- **Visible evidence base** Abstract text only; no methods, figures, tables, or supplementary materials provided
- **Missing materials affecting confidence** Full methods, detailed results, all SNP lists, pathogenicity prediction scores, conservation data, post-translational modification predictions, secondary structure analyses, functional interaction predictions, binding energy values, molecular dynamics simulation parameters and trajectories, and any statistical analyses

## Reviewer
- **Overall assessment** The abstract presents a plausible computational workflow for identifying deleterious SNPs in TERF1, but the evidence base is insufficient to evaluate the validity of the claims. The stepwise approach is reasonable, yet the abstract lacks quantitative results, validation against experimental data, and clarity on how the 4 SNPs were prioritized over the remaining 14. The clinical relevance claim regarding male infertility biomarkers is not supported by the provided evidence, as no direct association with infertility phenotypes is demonstrated. The manuscript may have merit, but the current abstract does not establish the case.
- **Who would be interested in the results, and why** Researchers in reproductive genetics, telomere biology, and computational genomics may find the results relevant. Those studying genetic markers for male infertility or telomere-associated disorders could use the identified SNPs as candidates for further experimental validation. However, the interest is contingent on the robustness of the computational predictions and their biological plausibility.
- **Major strengths** The study addresses a clinically relevant topic, male infertility, with potential translational implications. The computational pipeline is comprehensive, integrating multiple prediction tools and molecular dynamics, which is a systematic approach. The focus on TERF1, a key telomere protein, provides biological rationale for investigating its variants.
- **Major Concerns**  
  - **Concern ID** R1-M1  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The authors claim that 4 of 18 SNPs are the most damaging and highly deleterious, affecting TERF1 function and dynamics.  
  - **Evidence pointer** Abstract, location not provided  
  - **Concern** The abstract does not provide any quantitative data, such as prediction scores, stability changes, or binding energy values, to support the prioritization of these 4 SNPs. Without these data, the claim that these are the "most damaging" is unverifiable.  
  - **Why it matters** The core conclusion relies on the selection of these 4 SNPs, but the lack of numerical evidence prevents assessment of whether the filtering criteria were applied correctly or whether the results are robust.  
  - **Resolution test** Provide a table or supplementary data listing all 18 SNPs with their pathogenicity scores, stability predictions, conservation scores, and binding energy values, and clearly state the thresholds used for selection.  
  - **Concern ID** R1-M2  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Clinical relevance  
  - **Claim pointer** The authors suggest these polymorphisms should be used as genetic biomarkers for male infertility diagnosis.  
  - **Evidence pointer** Abstract, location not provided  
  - **Concern** The abstract does not present any data linking the identified SNPs to male infertility phenotypes, such as patient cohorts, allele frequencies in affected versus control groups, or functional assays. The claim of biomarker utility is speculative.  
  - **Why it matters** A biomarker claim requires evidence of association with the disease, which is absent. Overstating clinical applicability without such evidence could mislead readers.  
  - **Resolution test** Include case-control data or cite existing studies that demonstrate an association between these specific SNPs and male infertility, or temper the claim to suggest these are candidates for further investigation.  
  - **Concern ID** R1-M3  
  - **Severity** Major  
  - **Blocking** No  
  - **Axis** Methodological transparency  
  - **Claim pointer** The stepwise prediction approach is described, but details are missing.  
  - **Evidence pointer** Abstract, location not provided  
  - **Concern** The abstract lists the steps but does not specify the tools used, the criteria for "damaging" predictions, or how conflicting results were reconciled. This limits reproducibility.  
  - **Why it matters** Computational predictions are tool-dependent, and without specifying parameters and thresholds, the results cannot be independently verified.  
  - **Resolution test** In the full manuscript, provide a detailed methods section with tool names, versions, and thresholds, and describe how consensus was reached.
- **Minor Comments**  
  - **Concern ID** R1-m1  
  - **Severity** Minor  
  - **Axis** Clarity  
  - **Affected element** SNP selection rationale  
  - **Evidence pointer** Abstract, location not provided  
  - **Issue** The abstract states that 18 SNPs were analyzed, but the source of these SNPs (e.g., dbSNP, literature) is not mentioned.  
  - **Required correction** Specify the database or criteria used to select the initial 18 SNPs.  
  - **Concern ID** R1-m2  
  - **Severity** Minor  
  - **Axis** Terminology  
  - **Affected element** "Deleterious" usage  
  - **Evidence pointer** Abstract, location not provided  
  - **Issue** The term "deleterious" is used without defining whether it refers to predicted pathogenicity, structural impact, or functional effect.  
  - **Required correction** Define the operational meaning of "deleterious" in the context of the computational predictions.  
  - **Concern ID** R1-m3  
  - **Severity** Minor  
  - **Axis** Completeness  
  - **Affected element** Molecular dynamics outcomes  
  - **Evidence pointer** Abstract, location not provided  
  - **Issue** The abstract mentions effects on "flexibility and compaction" but does not specify the magnitude or direction of these changes.  
  - **Required correction** Provide quantitative descriptors, such as root-mean-square deviation or fluctuation values, in the abstract or refer to specific figures.
- **Technical failings that need to be addressed before the case is established** R1-M1 and R1-M2 are blocking. The lack of quantitative evidence for SNP prioritization and the absence of any phenotypic association undermine the core claims. Additionally, the methodological details are insufficient for reproducibility, though this is not blocking if the full manuscript provides them.

## Risk / unsupported claims
- The claim that the 4 SNPs are "most damaging" is unsupported without quantitative prediction data.
- The claim that these SNPs can be used as genetic biomarkers for male infertility is unsupported without case-control or functional evidence.
- The assertion that the SNPs affect TERF1-TERB1 interaction dynamics is not verifiable from the abstract alone, as no simulation results are provided.
- The general statement that TERF1 variants are linked to male infertility is referenced but not substantiated within the abstract.

## Assessment against Nature-style criteria
- **Originality** The application of a multi-step computational pipeline to TERF1 SNPs is not novel in itself, as similar approaches are common, but the specific focus on TERF1-TERB1 interaction may offer some novelty. However, the abstract does not demonstrate a unique contribution.
- **Scientific importance** Male infertility is a significant health issue, and identifying genetic markers is valuable. Yet, the importance is diminished by the lack of experimental validation or phenotypic data, making the findings preliminary.
- **Interdisciplinary readership** The topic bridges genomics, reproductive biology, and computational biology, which could attract a broad audience. However, the abstract's technical density without context may limit accessibility.
- **Technical soundness** The pipeline is plausible, but the abstract provides no evidence of its correct execution or validation. The absence of quantitative results prevents assessment of technical rigor.
- **Readability for nonspecialists** The abstract is concise but uses jargon without explanation, which may hinder nonspecialist understanding. The clinical relevance claim is clear but overstated.

## Recommendation posture
Currently not established from the provided evidence. The abstract presents a reasonable computational framework, but the lack of quantitative data and phenotypic association means the core claims cannot be evaluated. If the full manuscript provides detailed results, validation, and tempered conclusions, the work could be considered supportive. As presented, the case is not made.